Drug response prediction solution

Drug Response
Prediction Solution

Drug Response
Prediction Solution

Problem

Problem

The existing psychiatric diagnosis system

needs improvment for proper medication treatment

Existing psychiatric diagnostic system

needs improvement for appropriate medication treatment

Due to the lack of disease-specific drug prescriptions and insufficient objective indicators for drug specificity, an average of 4.3 years of inappropriate drug treatment is occurring.

Due to the lack of disease-specific drug prescriptions and insufficient objective indicators for drug specificity, an average of 4.3 years of inappropriate drug treatment is occurring.

Inappropriate treatment

Ratio

Delayed Period

Misdiagnosis & Prescribing
medication for other diseases

Diagnosis of bipolar disorder
in patients with depression

Diagnosis of bipolar disorder
in patients with schizophrenia

8.4%

31%

8.74 years

6.46 years

Prescribing drugs
with no effects

Depression

Schizophrenia

13.6%

36.7%

1.62 years

3 years

Scroll

SoLUTION

Analyzing optimal drug response for each patient in the clinical treatment process to improve the effectiveness of psychiatric medication treatment

01

Data collection

Collecting brainwave data through EEG devices.

02

Data analysis

Analyzing the patient's EEG data to identify drugs with high response

03

Providing analysis results

Provides a list of drugs with high response to doctors assisting prescriptions.

SoLUTION

Analyzing optimal drug response for each patient in the clinical treatment process to improve the effectiveness of psychiatric medication treatment

01

Data collection

Collecting brainwave data through EEG devices.

02

Data analysis

Analyzing the patient's EEG data to identify drugs with high response

03

Providing analysis results

Provides a list of drugs with high response to doctors assisting prescriptions.

Selecting clinical trial subjects for new drug development and analyzing the drug's efficacy

We provide clinical trial support solutions for pharmaceutical companies and biotech firms that develop psychiatric and new drugs. We select appropriate clinical trial subjects and distinguish between placebo effects to provide objective and quantitative indicators of trial efficacy.

Selecting clinical trial subjects for new drug development and analyzing the drug's efficacy

We provide clinical trial support solutions for pharmaceutical companies and biotech firms that develop psychiatric and new drugs. We select appropriate clinical trial subjects and distinguish between placebo effects to provide objective and quantitative indicators of trial efficacy.